文献速递其他结缔组织病

欧洲系统性硬化症患者全血转录组分析揭示复制验证的差异表达基因与通路

Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.
PubMed 文献 · Ann Rheum Dis · 2020-06-19

该研究在欧洲PRECISESADS项目框架下,对162例系统性硬化症(SSc)患者和252例对照的全血RNA进行测序分析,分发现集和验证集两阶段验证。共发现99个差异表达基因和225条功能通路在两组中均显著,复制的通路涉及I型干扰素、Toll样受体级联、p53功能及血小板脱颗粒与活化,中性粒细胞是SSc全血基因表达的主要决定因素。

要点

  • 全血转录组发现99个基因和225条通路在SSc中差异表达并在独立集复制验证。
  • 复制通路涉及I型干扰素、Toll样受体、p53、血小板脱颗粒与活化。
  • 中性粒细胞是SSc全血样本基因表达的主要决定细胞亚型。

核心结论

  • 在162例SSc患者和252例对照中发现并复制验证了一组差异表达基因和功能通路,涉及I型干扰素、Toll样受体级联、p53功能及血小板脱颗粒与活化等与自身免疫和SSc发病相关的失调过程。

研究设计与样本

  • 研究纳入162例SSc患者和252例对照,样本收集于RNA稳定剂中,分为发现集(79例患者+163例对照,南欧)和验证集(83例患者+89例对照,中西欧)。

主要发现

  • 复制的通路包括I型干扰素、Toll样受体级联、肿瘤抑制蛋白p53功能、血小板脱颗粒与活化的失调。
  • RNA转录本或FAIME评分与细胞亚型的联合相关分析显示强地理差异,中性粒细胞是SSc全血样本基因表达的主要决定因素。

关键数值与推荐

  • 在发现集和验证集两个人群中均显著的结果被视为复制验证。
  • RNA测序采用Illumina assay,Reactome通路功能注释采用FAIME算法,并行对28种循环细胞群体进行免疫表型分析。

临床怎么用

  • 全血转录组中复制验证的I型干扰素、Toll样受体、p53及血小板相关通路可作为SSc发病机制研究和潜在生物标志物探索的方向。
  • 中性粒细胞对SSc全血基因表达的主导贡献提示在解读全血转录组数据时需考虑细胞组成差异。

局限性

  • RNA转录本或FAIME评分与细胞亚型的相关性呈现强地理差异,可能影响跨人群推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The analysis of annotated transcripts from genome-wide expression studies may help to understand the pathogenesis of complex diseases, such as systemic sclerosis (SSc). We performed a whole blood (WB) transcriptome analysis on RNA collected in the context of the European PRECISESADS project, aiming at characterising the pathways that differentiate SSc from controls and that are reproducible in geographically diverse populations. METHODS: Samples from 162 patients and 252 controls were collected in RNA stabilisers. Cases and controls were divided into a discovery (n=79+163; Southern Europe) and validation cohort (n=83+89; Central-Western Europe). RNA sequencing was performed by an Illumina assay. Functional annotations of Reactome pathways were performed with the Functional Analysis of Individual Microarray Expression (FAIME) algorithm. In parallel, immunophenotyping of 28 circulating cell populations was performed. We tested the presence of differentially expressed genes/pathways and the correlation between absolute cell counts and RNA transcripts/FAIME scores in regression models. Results significant in both populations were considered as replicated. RESULTS: Overall, 15 224 genes and 1277 functional pathways were available; of these, 99 and 225 were significant in both sets. Among replicated pathways, we found a deregulation in type-I interferon, Toll-like receptor cascade, tumour suppressor p53 protein function, platelet degranulation and activation. RNA transcripts or FAIME scores were jointly correlated with cell subtypes with strong geographical differences; neutrophils were the major determinant of gene expression in SSc-WB samples. CONCLUSIONS: We discovered a set of differentially expressed genes/pathways validated in two independent sets of patients with SSc, highlighting a number of deregulated processes that have relevance for the pathogenesis of autoimmunity and SSc.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Beretta L, Barturen G, Vigone B, et al. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients. Ann Rheum Dis. 2020. PMID: 32561607. doi:10.1136/annrheumdis-2020-217116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。